Benjamin F. Edwards & Company, Inc. Pacira Bio Sciences, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 31, 2019	SELL	$41.31 - $52.16 $121,327 - $153,193	-2,937 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$32.85 - $52.0 $29,203 - $46,228	-889 Reduced 23.24%	2,937 $144,000
Q2 2018 Jul 19, 2018	SELL	$27.5 - $39.8 $68,255 - $98,783	-2,482 Reduced 39.35%	3,826 $123,000
Q1 2018 Apr 17, 2018	BUY	$29.98 - $46.35 $97,524 - $150,776	3,253 Added 106.48%	6,308 $196,000
Q4 2017 Jan 17, 2018	BUY	$31.85 - $46.95 $4,204 - $6,197	132 Added 4.52%	3,055 $139,000
Q3 2017 Oct 24, 2017	BUY	$35.7 - $39.5 $104,351 - $115,458	2,923	2,923 $110,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.